Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-25

Clinical Trial Update: Oxytocin Add on Study for Stable Schizophrenic Patients [NA]

View source ↗

Summary

A terminated clinical trial investigating oxytocin as an add-on treatment for stable schizophrenia patients; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: David Feifel | Conditions: Schizophrenia | NA | Status: TERMINATED | Results posted: 2019-09-25